Sign in

CIK 0001806310

  • Non-accelerated filer
  • Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843199512
Phone
+1 214-612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-01 Donenberg Phillip B. Director Grant or award +21,335 241,289
2026-06-01 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +42,671 42,671
2025-06-02 Donenberg Phillip B. Director Grant or award +56,623 219,954
2025-06-02 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +113,246 113,246
2024-05-29 Donenberg Phillip B. Director Grant or award +49,220 163,331
2024-05-29 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +98,440 98,440
2023-08-16 Donenberg Phillip B. Director Purchase +111,111 $0.90 $100K 114,111
2023-06-22 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +36,200 36,200
2022-06-17 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +15,500 15,500
2022-02-02 Donenberg Phillip B. Director Purchase +3,000 $7.78 $23K 3,000
2021-06-17 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +15,500 15,500
2020-09-23 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +31,000 31,000

Page 1 of 1 · 12 trades